7TM Pharma Receives Milestone Payment from Collaboration

7TM Pharma A/S has received an undisclosed milestone payment in their research collaboration with Ortho-McNeil-Janssen Pharmaceuticals Inc. The milestone was triggered by successful progress in selecting a pre-clinical candidate for the treatment of asthma and allergy.

In June 2005 7TM Pharma entered an exclusive worldwide license agreement and research collaboration with Ortho-McNeil to further develop 7TM Pharma's program on novel oral compounds for the treatment of asthma and allergy. The basis for the collaboration is 7TM Pharma's drug discovery platform, Site-Directed Drug Discovery and one of its resulting drug discovery programs targeting the discovery of novel antagonists to a certain 7-transmembrane receptor.

For further information please contact:

Mette Kirstine Agger,

CEO

Tel: +45 39 25 77 77...

Email: agger@7tm.com

Or visit www.7tm.com

Home > News & Events > News > 7TM Pharma Receives Milestone Payment from Collaboration
Last updated: 2008-05-29

The official Medicon Valley site is brought to you by the organisations Region Skåne and Copenhagen Capacity - in association with Medicon Valley Alliance

Contact:
Copenhagen Capacity,	tel: +45 33 22 02 22
Region Skåne,	tel: +46 (0)40 623 97 48

7TM Pharma A/S

7TM Pharma A/S is a privately held company, incorporated in 2000 as spin out from University of Copenhagen by internationally recognized pioneers in 7TM receptor research, Professor Thue W. Schwartz and Dr. Christian E. Elling alongside with industry-experienced Mette Kirstine Agger (CEO). The comp...